Abstract
Distinguishing cell types in peripheral blood smears is critical for diagnosing blood diseases, such as leukemia subtypes. Artificial intelligence can assist in automating cell classification. For training robust machine learning algorithms, however, large and well-annotated single-cell datasets are pivotal.
Here, we introduce a large, publicly available, annotated peripheral blood dataset comprising >40,000 single-cell images classified into 18 classes by cytomorphology experts from the Munich Leukemia Laboratory, the largest European laboratory for blood disease diagnostics. By making our dataset publicly available, we provide a valuable resource for medical and machine learning researchers and support the development of reliable and clinically relevant diagnostic tools for diagnosing hematological diseases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
SSB has received funding from F. Hoffmann-la Roche LTD (no grant number is applicable). SSB and SK are supported by the Helmholtz Association under the joint research school Munich School for Data Science - MUDS. AG has received funding from the LMU Munich Faculty of Medicine. CM has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (Grant Agreement No. 866411) and acknowledges support from the Hightech Agenda Bayern.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Informed consent was obtained indirectly, at the time of routine collection, for possible research. All patients in the MLL23 dataset were at least 18 years old. Ethics approval was granted by the Ethics Committee of LMU Munich (reference number 19-696).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
